Search results for: 'complex next'

Frost & Sullivan experts get together to present a series of executive briefings on the importance of emerging markets and why they are not just an option, but a necessity. We will be looking at the following markets through the course of 2012. 1. Latin America -Mexico and Colombia 2. Asia-Pacific - Sri Lanka 3. Asia Pacific- Malaysia and Thaila...

As enterprises execute their hybrid cloud strategies, they are looking to simplify critical functions, such as: --moving applications across various infrastructures --optimizing legacy applications --introducing new functionality and services to legacy and cloud applications Increasingly, they are choosing to build and deploy applications in con...

Declining diesel share gives rise to newer opportunities for electric vehicles. Understanding consumer needs becomes quintessential toward driving future mobility developments. This research focuses on consumer needs and their willingness to pay for various powertrain features and electric vehicles. The respondents were questioned based on numerous...

The top focal point in 2024 will be Artificial Intelligence (AI). Organizations across industries are working to understand the practical benefits to their operations and weigh those against the potential costs and risks. UCC providers are on the cusp of revolutionizing the communications industry through AI technologies but must win the confidence...

Affects of the pandemic, particularly widespread remote work and work from home practices, will have lasting impact on how people work and the communications and collaboration tools they use. The year 2022 promises to be a year of transition as COVID-19 infection rates decline globally and as end user organizations of all sizes, industries and regi...

Fastly has the potential to become a $500M company in 3 years and hit $1.5B in revenue within 10 years, while also increasing margins in the 70% range. All of the market trends and data points to a big growth opportunity for companies like Fastly over the next few years as more customers demand greater flexibility and better performance across thei...

Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times. Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics. Artificial Intelligence (AI) an...

Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...

19 Jan 2018  |  North America  |  Market Research

The Global Immuno-oncology Therapeutics Market—Adoptive T-cell Therapies, Forecast to 2022

The Next Generation of Cancer Therapies

Infographics

×

Key Issues Addressed

Immuno-oncology refers to drugs that are used to stimulate the human immune system to target the fight against cancer. The immune system is capable of recognizing and eliminating foreign substances, including tumor cells. Tumors have, however, been able to escape detection by the immune system. There are drugs that can empower the immune system cel...